XML 23 R7.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Statements of Equity (Deficit) (Unaudited) - USD ($)
$ in Thousands
Total
Series A Preferred Stock
Series B Preferred Stock
Preferred Stock
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Deficit
Series A Preferred Stock
Accumulated Deficit
Series B Preferred Stock
Accumulated Other Comprehensive Income (Loss)
Noncontrolling Interests
Beginning balance (in shares) at Dec. 31, 2023       4,563 29,937,067            
Beginning balance at Dec. 31, 2023 $ 359,566     $ 0 $ 3 $ 572,170 $ (281,285)     $ 229 $ 68,449
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Vesting of restricted stock and other, net of shares withheld for employer taxes (in shares)         158,236            
Vesting of restricted stock and other, net of shares withheld for employer taxes (1,170)         (1,170)          
Share based payments 8,611         8,611          
Share based payments in equity of subsidiary 36         36          
Dividends on common stock (15,093)           (15,093)        
Dividends on preferred stock   $ (1,218)           $ (1,218)      
Net (loss) income (47,954)           (49,165)       1,211
Distributions to noncontrolling interests (954)                   (954)
Contributions from noncontrolling interests 2,502                   2,502
Other comprehensive loss (3,872)                 (3,872)  
Ending balance (in shares) at Mar. 31, 2024       4,563 30,095,303            
Ending balance at Mar. 31, 2024 299,657     $ 0 $ 3 579,647 (347,558)     (3,643) 71,208
Beginning balance (in shares) at Dec. 31, 2024       4,563 30,499,931            
Beginning balance at Dec. 31, 2024 (456,016)     $ 0 $ 3 589,387 (1,070,996)     (6,569) 32,159
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
RSU equity awards reclassified to liability (2,138)         (2,138)          
Common stock retired (in shares)         (2,865)            
Warrants issued 863         863          
Share based payments 3,143         3,143          
Share based payments in equity of subsidiary 316         23         293
Vesting of shares in equity of subsidiary (71)         (71)         0
Dividends on preferred stock     $ (797)           $ (797)    
Net (loss) income (16,567)           (9,975)       (6,592)
Common stock issuance in equity of subsidiary 1,575                   1,575
Disposition from sale and deconsolidation of businesses 2,918                   2,918
Initial consolidation of VIE 12,494                   12,494
Other comprehensive loss (487)                 (487)  
Ending balance (in shares) at Mar. 31, 2025       4,563 30,497,066            
Ending balance at Mar. 31, 2025 $ (453,970)     $ 0 $ 3 $ 591,207 $ (1,080,971)     $ (7,056) $ 42,847